Millipore NovAseptic® Aseptic Design Valve
| Brand | Millipore |
|---|---|
| Origin | USA |
| Model | NovAseptic® Aseptic Design Valve |
| Valve Body Diameter Range | 12 mm to 76 mm |
| CIP/SIP Compatibility | Yes |
| Zero-Dead-Leg Design | Yes |
| Drainability | Full Drainage |
| Regulatory Compliance | Designed for FDA-regulated bioprocessing environments (21 CFR Part 11–ready software integration supported) |
| Customization | Available for client-specific fluidic architecture and actuation requirements |
Overview
The Millipore NovAseptic® Aseptic Design Valve is an engineered solution for critical fluid handling in aseptic biomanufacturing processes. Developed over two decades of applied experience in sterile process engineering, this valve series adheres rigorously to the fundamental principles of aseptic design—eliminating microbial harborage points, ensuring complete system drainage, and enabling reproducible validation of cleaning and sterilization cycles. Unlike conventional sanitary valves, the NovAseptic® platform integrates a zero-dead-leg geometry, precision-machined flow paths, and fully drainable internal architecture to meet stringent requirements for biopharmaceutical upstream and downstream operations—including cell culture media transfer, buffer preparation, chromatography skid integration, and final fill/finish lines. Its operation is based on a hygienic quarter-turn rotary actuation mechanism with metal-to-metal or elastomer-sealed configurations, optimized for compatibility with steam-in-place (SIP) at 121–135 °C and clean-in-place (CIP) using caustic, acid, or solvent-based regimes per ISPE Baseline Guide and ASME BPE-2023 standards.
Key Features
- Zero-Dead-Leg Architecture: Internal flow passages are contoured to eliminate stagnant zones where microorganisms could proliferate; all wetted surfaces conform to ASME BPE surface finish specifications (Ra ≤ 0.4 µm for electropolished stainless steel variants).
- Full Drainability: Valve orientation and internal geometry support gravity-assisted complete evacuation of process fluids—critical for minimizing carryover between batches and reducing cleaning validation burden.
- CIP/SIP Compatibility: Validated for repeated exposure to high-temperature saturated steam (up to 135 °C, 30 min) and aggressive chemical cleaners without seal degradation or dimensional drift.
- Modular Actuation Options: Available with pneumatic, electric, or manual actuators; position feedback and limit switches support integration into PLC-controlled bioprocess automation systems compliant with ISA-88 and ISA-95 frameworks.
- Scalable Sizing: Standard body diameters range from 12 mm to 76 mm (½″ to 3″), with custom port configurations (e.g., tri-clamp, ISO-KF, DIN 11851) and material options (316L SS, EPDM/FKM diaphragms, PTFE-coated components) available per application risk assessment.
Sample Compatibility & Compliance
The NovAseptic® valve is qualified for use with mammalian cell culture media, viral vectors, monoclonal antibodies, plasmid DNA, and other sensitive biologics requiring Grade A/B environments per EU GMP Annex 1 (2022). It supports compliance with USP , ISO 13408-1, and ASTM F2897 for aseptic processing equipment. All elastomeric components undergo extractables and leachables profiling per USP and . The valve’s design documentation includes full traceability of raw materials, weld logs, surface finish verification reports, and FAT/SAT protocols aligned with GAMP 5 practices.
Software & Data Management
While the NovAseptic® valve itself is hardware-based, its actuation interface supports digital integration via 4–20 mA analog signals, Profibus DP, or Ethernet/IP. When paired with Millipore’s integrated control platforms (e.g., Mobius® Solutions), it enables electronic batch record linkage, audit trail generation per FDA 21 CFR Part 11, and automated cycle logging for CIP/SIP execution—including temperature ramp rates, hold times, pressure differentials, and valve position timestamps. Firmware updates follow IEC 62443-3-3 security guidelines.
Applications
- Single-use and stainless-steel bioreactor harvest lines
- Aseptic transfer between buffer preparation tanks and TFF cassettes
- Chromatography column inlet/outlet isolation in multi-column continuous processing
- Final sterile filtration manifold routing in vial/flex-bag filling suites
- Cell therapy manufacturing workflows requiring closed-system connectivity
FAQ
What regulatory standards does the NovAseptic® valve comply with?
It is designed to meet ASME BPE-2023, EU GMP Annex 1 (2022), and USP requirements for aseptic process equipment.
Can the valve be validated for SIP at 135 °C?
Yes—qualified for repeated SIP cycles up to 135 °C for 30 minutes with appropriate elastomer selection (e.g., FKM or silicone variants).
Is full traceability documentation provided?
Yes—includes material certifications (EN 10204 3.1), weld maps, surface roughness reports, and FAT/SAT summary packages.
Does Millipore offer engineering support for system integration?
Yes—dedicated bioprocess engineering teams provide piping and instrumentation diagram (P&ID) review, risk assessment (FMEA), and commissioning support.
Are replacement parts and service kits available globally?
Yes—standardized spare kits (seals, actuators, positioners) are stocked through Millipore’s regional distribution centers in North America, EMEA, and APAC.
